Onset and development of cyclosporin A effects on lymphocytes of cardiac patients before heart transplantation.
The effects of cyclosporin A (CSA) in low dosage (4 mg/kg/24 h i.v.) were studied in 17 patients awaiting heart transplantation. The lymphocyte subsets were typed, enumerated, and their proliferation measured before CSA perfusion, after infusion (over 24 h), and then again after two further 24 h intervals (T0 h, T24 h, T48 h, and T72 h). No significant change was found in T or B enumerations although lymphocyte function was markedly modified. For all 17 patients, there was a significant decrease in lymphocyte proliferation that was, however, re-established after 72 h for 14 of the patients, but not for the remaining 3. Inhibition of the proliferative response was found to occur rapidly, to be potent although rapidly reversible in most cases, while yet subject to wide interindividual variability. These four features suggest that (a) CSA in fixed doses may later the balance between helper and suppressor cells in varying degrees according to the patient, and that (b) CSA given immediately or shortly after heart transplantation could be beneficial.
Albengres
E
E
Laboratoire de Pharmacologie, Hôpital Intercommunal, Créteil, France.
Riant
P
P
Morel
M
M
Hamberger
C
C
Tavolaro
O
O
Loisance
D
D
Tillement
J P
JP
Cachera
J P
JP
D000328:Adult; D000368:Aged; D009202:Cardiomyopathies / Q000276:immunology* / Q000601:surgery; D003524:Cyclosporins / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D016027:Heart Transplantation; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology
D003524:Cyclosporins; D008934:Mitogens